Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-13T01:47:57.582Z Has data issue: false hasContentIssue false
  • English
  • Français

Risk of Multiple Sclerosis after Idiopathic Optic Neuritis in a Pakistani Population

Published online by Cambridge University Press:  02 December 2014

Syed Faraz Kazim ,
Muhammad Islam ,
Mustafa Khan ,
Bilal Hameed  and
Saad Shafqat
Syed Faraz Kazim
Affiliation:
Section of Neurology, Aga Khan University Hospital, Karachi, Pakistan
Muhammad Islam
Affiliation:
Clinical Epidemiology Unit, Aga Khan University Hospital, Karachi, Pakistan
Mustafa Khan
Affiliation:
Clinical Neurophysiology Laboratory, Aga Khan University Hospital, Karachi, Pakistan
Bilal Hameed
Affiliation:
Clinical Neurophysiology Laboratory, Aga Khan University Hospital, Karachi, Pakistan
Saad Shafqat*
Affiliation:
Section of Neurology, Aga Khan University Hospital, Karachi, Pakistan
*
Department of Medicine (Neurology), Aga Khan University Hospital, Stadium Road, Karachi 74800, Pakistan.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background and objective:

Optic neuritis (ON) is associated with a 38% ten-year risk of developing multiple sclerosis (MS) in Western populations, but the corresponding risk in non-Western populations is unclear. We conducted this study to estimate the risk of progression to MS after an episode of ON in a South Asian population.

Methods:

Two hundred and fifty-three patients with idiopathic ON were identified by reviewing records of visual evoked potentials and chart notes from a single academic center spanning the years 1990-2007. A structured telephone interview was then conducted to identify patients who had subsequently received a diagnosis of MS. The diagnosis was corroborated from chart notes, where possible. Cumulative probability of conversion to MS was calculated using Kaplan-Meier survival analysis.

Results:

The five-year risk of developing MS was 14.6% and the ten-year risk was 24%. Patients (N=218) who had one or more typical demyelinating lesions on baseline brain magnetic resonance imaging (MRI) had a 68% 10-year risk; those with no lesions or non-typical lesions had a 14% risk (p<0.001). Female gender, recurrent ON, and occurrence of ON in winter months were also associated with increased risk (p≤ 0.001). Severity of ON and likelihood of detecting cerebrospinal fluid (CSF) oligoclonal bands were higher in patients who developed MS.

Conclusion:

Idiopathic ON in Pakistan carries a lower risk of progression to MS compared with Western data. As in Western populations, however, presence of abnormal baseline brain MRI and CSF oligoclonal bands correlate with increased MS risk.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 37 , Issue 2 , March 2010 , pp. 258 - 263
Copyright
Copyright © The Canadian Journal of Neurological 2010

References

1. Optic Neuritis Study Group. The 5-year risk of MS after optic neuritis: experience of the optic neuritis treatment trial. Neurology. 1997;49(5):1404–13.Google Scholar
2. Beck, RW, Trobe, JD, Moke, PS, Gal, RL, Xing, D, Bhatti, MT, et al. High- and low- risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of optic neuritis treatment trial. Arch Ophthalmols. 2003;121(7):944–9.Google Scholar
3. Beck, RW, Smith, CH, Gal, RL, Xing, D, Bhatti, MT, Brodsky, MC, et al. Neurologic impairment 10 years after optic neuritis. Arch Neurol. 2004;61(9):1386–9.Google Scholar
4. Optic Neuritis Study Group. Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up. Arch Neurol. 2008;65(6):727–32.Google Scholar
5. Sandberg, - Wollheim, M, Bynke, H, Cronqvist, S, Holtas, S, Platz, P, Ryder, LP. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol. 1990;27(4):386–93.Google Scholar
6. Balcer, LJ. Clinical practice. Optic neuritis. N Engl J Med. 2006;354(12):1273–80.Google Scholar
7. Arnold, AC. Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol. 2005;139(6):1101–8.CrossRefGoogle ScholarPubMed
8. Frohman, EM, Frohman, TC, Zee, DS, McColl, R, Galetta, S. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol. 2005;4(2):111–21.Google Scholar
9. Pirko, I, Blauwet, LK, Lesnick, TG, Weinshenker, BG. The natural history of recurrent optic neuritis. Arch Neurol. 2004;61(9):1401–5.CrossRefGoogle ScholarPubMed
10. Rodriguez, M, Siva, A, Cross, SA, O’Brien, PC, Kurland, LT. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology. 1995;45(2):244–50.Google Scholar
11. Optic Neuritis Study Group. The clinical profile of acute optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol. 1991;109(12):1673–8.CrossRefGoogle Scholar
12. Wasay, M, Khatri, IA, Khealani, B, Sheerani, M. MS in Asian countries. Int MS J. 2006;13(2):58–65.Google Scholar
13. Wingerchuk, DM, Hogancamp, WF, O’Brien, PC, Weinshenker, BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999;53(5):1107–14.Google Scholar
14. CHAMPS Study Group. Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis. Am J Ophthalmol. 2001;132(4):463–71.Google Scholar
15. Rizzo, J F 3rd, Lessell, S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology. 1988;38(2):185–190.Google Scholar
16. Söderström, M, Ya-Ping, J, Hillert, J, Link, H. Optic neuritis: prognosis for multiple sclerosis from MRI, CSF, and HLA findings. Neurology. 1998;50(3):708–14.Google Scholar
17. Lin, YC, Yen, MY, Hsu, WM, Lee, HC, Wang, AG. Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan. Jpn J Ophthalmol. 2006;50(2):170–5.Google Scholar
18. Lana-Peixoto, MA, Lana-Peixoto, MI. The risk of multiple sclerosis developing in patients with idiopathic optic neuritis in Brazil. Arq Neuropsiquiatr. 1991;49(4):377–83.Google Scholar
19. Singhal, BS. Multiple sclerosis - Indian experience. Ann Acad Med Singapore. 1985;14(1):32–6.Google ScholarPubMed
20. Singhal, BS. Multiple sclerosis. Neurol India. 1999;47(1):1–2.Google Scholar
21. Nilsson, P, Larsson, E M, Maly, - Sundgren, P, Perfekt, R, Sandberg Wollheim, M. Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up. J Neurol. 2005;252(4):396–402.CrossRefGoogle ScholarPubMed
22. Tumani, H, Tourtellotte, WW, Peter, JB, Felgenhauer, K. Acute optic neuritis: combined immunological markers and magnetic resonance imaging predict subsequent development of multiple sclerosis. The Optic Neuritis Study Group. J Neurol Sci. 1998;155(1):44–9.Google Scholar
23. Bansil, S, Singhal, BS, Ahuja, GK, Riise, T, Ladiwala, U, Behari, M, et al. Multiple sclerosis in India: a case-control study of environmental exposures. Acta Neurol Scand. 1997;95(2):90–5.Google Scholar
24. Stendahl-Brodin, L, Link, H. Optic neuritis: oligoclonal bands increase the risk of multiple sclerosis. Acta Neurol Scand. 1983;67(5):301–4.Google Scholar
25. Beck, RW, Cleary, PA, Trobe, JD, Kaufman, DI, Kupersmith, MJ, Paty, DW, et al. The effects of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med. 1993;329(24):1764–9.Google Scholar